Pune, India, November 2018/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Bioprocess Containers Market.
The Global Bioprocess Container is anticipated to have held a market value of USD 990 million in the year 2017 and is expected to grow at a CAGR of 13.8% during the forecast period. Bioprocess Containers are single-use used for the liquid-handling process in the biopharmaceutical companies.
Growing pharmaceutical and biotech industry and increasing demand for biological products are expected to drive the growth of the market. On the other hand, high issue related leachables and extractables restrain the market growth over the forecast period.
Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and rising demand for biological products. Europe is expected to hold the second largest position in the global market owing to the growing pharma and biotech industry. Asia-Pacific is expected to be the fastest growing market owing to the increasing biopharmaceutical industry. Furthermore, the Middle East and Africa region is expected to account for the least market share in the global market.
Access Report Details @ https://www.marketresearchfuture.com/reports/bioprocess-containers-market-6632
The Global Bioprocess Containers Market has been segmented into type, application, and end user.
Based on type, the market is segmented into 2D container, 3D container, and accessories. The 2D container segment is expected to account for the largest share segment of the global market in 2017.
Based on application, the market is segmented into production process, upstream process, and downstream process.
Based on end user, the market segmented into pharmaceutical companies, biotechnology companies, and other end users.
Some of the prominent players in the global bioprocess containers market are GE Healthcare (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Sartorius (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Rim Bio (US), Fluids Control (Argentina), and Meissner (US).